Evaluation of immune activation in HIV-infected and uninfected African individuals by single-cell analysis of cytokine production

Journal of Acquired Immune Deficiency Syndromes

Volumn 28, Issue 5, 2001, Pages 429-436

  Lukwiya, Matthew ^a   Rizzardini, Giuliano ^b   Trabattoni, Daria ^c   Piconi, Stefania ^d   Saresella, Marina ^e   Declich, Silvia ^f   Fossati, Sabrina ^c   Clerici, Mario ^c  

^a St Mary's Hospital Lacor Uganda   (Uganda)

^b OSPEDALE DI CIRCOLO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^f ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Africa; Cytokine; HIV infection; Immune activation; Immunity

Indexed keywords

CD28 ANTIGEN; ENVELOPE PROTEIN; GAMMA INTERFERON; GLYCOPROTEIN GP 160; INTERLEUKIN 10; MITOGENIC AGENT; MONOCLONAL ANTIBODY; STAPHYLOCOCCUS ENTEROTOXIN B; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; IMMUNOSTIMULATION; ITALY; LYMPHOCYTE COUNT; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; UGANDA;

EID: 0035894220     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200112150-00004     Document Type: Article

References (35)

1. Immune activation is a dominant factor in the pathogenesis of African AIDS
2. Pathogenesis of HIV in Africa: Lessons from the Ethiopian immigrant in Israel
3. Immunologic activation markers in the serum of African and European HIV seropositive and seronegative individuals
4. Immune activation in HIV-infected African individuals
5. Immune activation in Africa is environmentally-driven and is associated with upregulation of CCR5
6. Genetic and biological characterization of HIV-1 strains from Cameroon
7. V3 sequence analysis and biological characterization of HIV-1 isolates from asymptomatic and early symptomatic Tanzanian individuals
8. HIV-1 subtype C syncytium- and non syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS
9. HIV infection amongst employees in an African hospital
10. Survival time of patients with AIDS: Experience with 274 patients in Dar el Salaam
11. Seroconversion rate, mortality and clinical manifestations associated with the receipt of an HIV infected blood transfusion in Kinshasa, Zaire
12. The epidemiology of HIV infection and AIDS in Africa
13. Natural history and spectrum of disease in adults with HIV/AIDS in Africa
14. An HIV-1 natural history cohort and survival times in rural Uganda
15. IL-2 production permits detection of antigenic peptide recognition by T helper lymphocytes from asymptomatic, HIV seropositive individuals
16. Restoration of cytomegalovirus-specific CD4(+) T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1
17. HIV-1-specific CD4(+) T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
18. Normal human CD4(+) memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis
19. Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individual
20. Induction of expression of HIV in latently or chronically infected cells
21. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination
22. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1
23. Immunization with both T cell-dependent and T cell-independent vaccines augments HIV viral load secondarily to stimulation of TNF
24. The effect of acute infectious illnesses on plasma HIV-1 viral load and the expression of serologic markers of immune activation among HIV-infected adults
25. Trend in HIV prevalence in an antenatal clinic in North Uganda and adjusted rates for the general female population
26. Tumor necrosis factor-cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages
27. Tumor necrosis factor activates human immunodeficiency virus type 1 trough induction of nuclear factor binding to the NF-κB site long terminal repeat
28. Sustained plasma TNF and HIV-1 viral load despite resolution of other parameters of immune activation during treatment of tuberculosis in Africa
29. Heteroduplex mobility assay and phylogenetic analyses of V3 region sequences of HIV-1 isolates from Gulu, Northern Uganda
30. Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda
31. A molecular epidemiology survey of HIV in Uganda
32. Predominance of HIV-1 subtype A and D infections in Uganda
33. Correlates of HIV-1 specific mucosal IgA in a cohort of highly exposed, HIV-1 seronegative Kenyan sex workers
34. Transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells